ERBA Diagnostics, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net revenue of $7,540,657 compared to $6,889,259 a year ago. This increase is primarily attributed to an increase in revenues at European operations, and an improvement in instrument and reagents orders in the international market. Income from operations was $553,970 compared to $87,552 a year ago. Income before provision for income taxes was $479,950 compared to $99,033 a year ago. Net income was $450,436 or $0.01 per basic and diluted share compared to $87,333 or $0.00 per basic and diluted share a year ago. The increase in net income was primarily related to the growth in sales and the decrease in operating expenses.

For the six months, the company reported net revenue of $13,911,769 compared to $13,597,366 a year ago. Income from operations was $803,217 compared to $151,383 a year ago. Income before provision for income taxes was $673,725 compared to loss before provision for income taxes of $107,025 a year ago. Net income was $614,682 or $0.01 per diluted share compared to net loss of $159,719 or $0.01 per diluted share a year ago.